Latamoxef

Modify Date: 2024-01-01 19:44:31

Latamoxef Structure
Latamoxef structure
Common Name Latamoxef
CAS Number 64952-97-2 Molecular Weight 520.47300
Density 1.77 g/cm3 Boiling Point 836ºC
Molecular Formula C20H20N6O9S Melting Point 117 - 122ºC
MSDS USA Flash Point N/A

 Use of Latamoxef


Moxalactam (Latamoxef) is a synthetic oxa-β-lactam antibiotic. Moxalactam has a broad spectrum of activity against Gram-positive and Gram-negative aerobic and anaerobic bacteria. Moxalactam inhibits production of β-lactamases[1].

 Names

Name moxalactam
Synonym More Synonyms

 Latamoxef Biological Activity

Description Moxalactam (Latamoxef) is a synthetic oxa-β-lactam antibiotic. Moxalactam has a broad spectrum of activity against Gram-positive and Gram-negative aerobic and anaerobic bacteria. Moxalactam inhibits production of β-lactamases[1].
Related Catalog
Target

β-lactamases[1]

In Vitro Moxalactam (Latamoxef) inhibits 90% of strains of Escherichia coli, Klebsiella species, Proteus species, Morganella morganii, Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae and Salmonella species, including strains which are resistant to Cephalothin (HY-B1275A) and Gentamicin (HY-A0276A) at concentrations of less than 1 μg/mL[1]. Moxalactam exhibits moderate activity against P. aeruginosa and is usually active against other species of Pseudomonas, Acinetobacter species are usually resistant to Moxalactam[1]. Moxalactam has marked stability in vitro against a variety of β-lactamases, including that produced by B. fragilis, inhibits production of β-lactamases and does not induce class I β-lactamase[1].
In Vivo Moxalactam (Latamoxef) (0-7.4 mg/mouse; s.c.; once) is effective against bacterial infections in mice[2]. Animal Model: Four-week-old male strain ICR mice, weighing 18-20 g, bacterial infection model[2] Dosage: 0-7.4 mg/mouse Administration: Subcutaneous injection, once Result: Showed protective activity with ED50s less than 7.4 mg/mouse against gram-positive and gram-negative bacterial infected mice.
References

[1]. Carmine AA, et al. Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1983 Oct;26(4):279-333.

[2]. Goto S. In vitro and in vivo antibacterial activity of moxalactam, an oxa-β-lactam antibiotic. Clinical Infectious Diseases, 1982, 4(Supplement_3): S501-S510.

 Chemical & Physical Properties

Density 1.77 g/cm3
Boiling Point 836ºC
Melting Point 117 - 122ºC
Molecular Formula C20H20N6O9S
Molecular Weight 520.47300
Exact Mass 520.10100
PSA 231.60000
Index of Refraction 1.768

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
RN6824500
CHEMICAL NAME :
5-Oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((carboxy(4-hydroxyphenyl)acetyl) amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio) methyl)-8-oxo-
CAS REGISTRY NUMBER :
64952-97-2
LAST UPDATED :
199504
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C20-H20-N6-O9-S
MOLECULAR WEIGHT :
520.52

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
480 mg/kg/4D-I
TOXIC EFFECTS :
Blood - hemorrhage
REFERENCE :
AIMEAS Annals of Internal Medicine. (American College of Physicians, 4200 Pine St., Philadelphia, PA 19104) V.1- 1927- Volume(issue)/page/year: 99,126,1983 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X5300 No. of Facilities: 69 (estimated) No. of Industries: 1 No. of Occupations: 5 No. of Employees: 5145 (estimated) No. of Female Employees: 4707 (estimated)

 Safety Information

Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
RIDADR NONH for all modes of transport
WGK Germany 3
RTECS RN6824500

 Articles26

More Articles
A potential substrate binding conformation of β-lactams and insight into the broad spectrum of NDM-1 activity.

Antimicrob. Agents Chemother. 56(10) , 5157-63, (2012)

New Delhi metallo-β-lactamase 1 (NDM-1) is a key enzyme that the pathogen Klebsiella pneumonia uses to hydrolyze almost all β-lactam antibiotics. It is currently unclear why NDM-1 has a broad spectrum...

Comparison of cefoxitin and moxalactam 30 microg disc diffusion methods for detection of methicillin resistance in coagulase-negative staphylococci.

J. Antimicrob. Chemother. 59(4) , 763-6, (2007)

To compare cefoxitin and/or moxalactam 30 microg disc diffusion (DD) methods to detect methicillin resistance in coagulase-negative staphylococci (CoNS) using both high- and low-density (HD/LD) inocul...

Phosphate deprivation is associated with high resistance to latamoxef of gel-entrapped, sessile-like Escherichia coli cells.

J. Antimicrob. Chemother. 49(2) , 315-20, (2002)

Viable Escherichia coli cells were entrapped in agar gel layers and incubated in a phosphate-limited glucose medium. Immobilized bacteria displayed enhanced alkaline phosphatase activity and overexpre...

 Synonyms

5-Oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid,7-((carboxy(4-hydroxyphenyl)acetyl) amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo
7-((Carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-(3-((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Latamoxef
lamoxactam
(R)-Moxalactam
5-oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid,7-((carboxy(4-hydroxyphen
Listeria MOX Supplement,Moxalactam
Oxa-cephem
yl)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo
LMOX
Top Suppliers:I want be here

Get all suppliers and price by the below link:

Latamoxef suppliers

Latamoxef price